BEVISPAS
Tablet 20s 100s
registration number
29/11.2/0255
What BEVISPAS is and what it is used for
BEVISPAS is indicated for:
• Primary irritable colon characterised by persistent diarrhoea, alternating constipation and diarrhoea, abdominal pain and postprandial distension.
• Secondary irritable colon due to organic lesions such as diverticulitis, regional enteritis, specific and non-specific inflammatory conditions of the gastrointestinal tract.
dosage
Take 135 mg mebeverine hydrochloride (one tablet) three times daily, preferably before meals. After a period of a few weeks the dosage may be gradually reduced once the desired effect has been obtained.
how to take
For oral administration.
What BEVISPAS contains
Each film-coated tablet of BEVISPAS contains 135 mg mebeverine hydrochloride.
other ingredients
Lactose monohydrate, macrogol, magnesium stearate, polyvinyl alcohol, starch maize, talc, titanium dioxide (C.I. 77891).
Contains sugar: Lactose monohydrate 100,00 mg.
Therapeutic classification
A 11.2 Gastrointestinal antispasmodics and cholinolytics (anticholinergics).